Reaction from Uğur Şahin to Joe Biden
BioNTech's founder Uğur Şahin also drew attention to the factory, raw material and supply chain needed to produce vaccines by reacting to Joe Biden's patent statements.
12 May 2021 10:23Updated: 12 May 2021 10:24
Uğur Şahin, the founder of BioNTech, who developed a coronavirus vaccine with
Pfizer , responded to the patent and intellectual property issues that have come to the fore recently with a very harsh statement.
"Developed countries should understand this, it will not work once to help," said Şahin.
A very sharp and clear statement came from BioNTech's founder, Uğur Şahin, after US President Joe Biden's statement, “I support vaccine companies to waive the protection of intellectual property”.
Responding to many countries making similar statements after Biden's statement, Şahin spoke to Der Spiegel, one of Germany's respected magazines.
Following Biden's statements, while the shares of Moderna, BioNTech and Pfizer companies lost value in the stock market, Şahin said that it is meaningless to waive patents and intellectual property.
'DEVELOPED COUNTRIES SHOULD UNDERSTAND…'
According to the news in Sözcü Şahin, “Developed countries should understand that, helping once is not enough. Governments, producers and institutions should regularly help poor countries. BioNTech provides vaccines to such countries at low prices with no profit making. Waiving the protection of intellectual property is not a solution, ”he said.
"Patents are not limiting factors in the production or supply of the vaccine," Şahin said. The abolition of patents will not increase global vaccine production or supply in the near or medium term. "The bottleneck in the process is not the little known formula, but access to raw materials, the number of factories and an efficient supply chain," he continued.
Şahin also said that the focus of the company is not "only coronavirus" and said, "We want to improve our technology, we want to produce HIV, tuberculosis and influenza vaccines as well as cancer vaccines. There are also new demands. "Developing a malaria vaccine will also be a new priority."
Pfizer ile birlikte koronavirüsü aşısı geliştiren BioNTech'in kurucusu Uğur Şahin son dönemde gündeme gelen patent ve fikri mülkiyet
www.veryansintv.com
nos.nl
